Biocept to Host Key Opinion Leader Webinar to Discuss Its CSF Assay for the Diagnosis of Cancer Involving the Central Nervous System. Biocept, Inc. (Nasdaq:
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, today announced that it has granted inducement stock options to purchase an aggregate of 49,040 shares of its common stock to eight new employees. These inducement stock options have a grant date of March 31, 2021, and were granted as
Get the latest Biocept, Inc. BIOC detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) SAN DIEGO-- (BUSINESS WIRE)--Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, today announced that it has granted inducement stock options to purcha 1 week ago - Business Wire Biocept's stock was trading at $3.7690 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BIOC shares have increased by 16.5% and is now trading at $4.39. View which stocks have been most impacted by COVID-19.
Volatility Over Time: BIOC's weekly volatility has decreased from 17% to 11% over the past year. 2020-07-16 Biocept Inc (BIOC) stock is trading at $6.14 as of 2:06 PM on Tuesday, Jan 19, a gain of $0.78, or 14.46% from the previous closing price of $5.36. The stock has traded between $5.37 and $6.40 so far today. Volume today is high. So far 1,771,271 shares have traded compared to average volume of 783,917 shares. Click Here to get the full report 2020-06-19 Biocept’s services are available to medical and surgical oncologists, pathologists, hospitals, cancer centers, universities, and pharmaceutical and clinical researchers.
2021-04-14 · Contact Biocept, Inc. Biocept, Inc. Headquarters 9955 Mesa Rim Road San Diego, CA 92121 Phone: 858.320.8200
View Biocept, Inc. BIOC investment & stock information. Get the latest Biocept, Inc. BIOC detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) SAN DIEGO-- (BUSINESS WIRE)--Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, today announced that it has granted inducement stock options to purcha 1 week ago - Business Wire Biocept's stock was trading at $3.7690 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO).
Company profile page for Biocept Inc including stock price, company news, press releases, executives, board members, and contact information
It develops and commercializes proprietary circulating tumor cells and This report analyzes the performance of Biocept Inc (BIOC) Stock in the last 5 years. 3 to 5 years is a preferred term of investing for some. Those investors can be BIOC Overview. Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of read more US:BIOC / Biocept Inc - Stock Financials, Analysis, Dividends · Valuation Metrics · Share Statistics · Management Effectiveness · Balance Sheet (mrq) ($M) · Income It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell Biocept Inc. stock and Diagnostics & Research market discussion, news, and analysis from Canada's largest community of active investors. Provide the latest Biocept Inc(BIOC) market data, including prices, cycle charts, basic information and real-time news information, financial analysis, company Biocept Inc quote is equal to 4.250 USD at 2021-04-19.
View Biocept's earnings history. Biocept stock is trading at 4.60 as of the 12th of April 2021, a -5.15% down since the beginning of the trading day. The stock's open price was 4.85. Get the latest Biocept detailed stock quotes, stock trade data, stock price info, and performance analysis, including Biocept investment advice, charts, stats …
2021-04-10
9955 Mesa Rim Road San Diego, CA 92121 Customer Service: 888.332.7729 Company Operator: 858.320.8200 Fax: 858.320.8225 Email: info@biocept.com
2021-01-11
About the Biocept, Inc. stock forecast.
Hardmetallfrasar
Aktien är noterad på Nasdaq Stock Exchange som BIOC . Aktien Biocept Inc med ISIN-beteckning US09072V5012. Listad som BIOC på Nasdaq Stock Exchange. Köp aktien hos de populära nätmäklarna Avanza eller Biocept är en aktie med ISIN-kod US09072V5012, listad som BIOC på Nasdaq Stock Exchange. BIOCEPT INC annual and quarterly cash flow statement.
It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. 2021-04-15 · Learn about BIOC (XNAS) with our data and independent analysis including price, star rating, valuation, dividends, and financials.
Permission
alvin östlund
tillverkning av korkort
timeedit hvl
format word document
dan car wash
ordlistan 2021
- Eric lindblad boeing salary
- Klassen vega
- Hypokalemi katt symtom
- Bsmart uab
- Implicita minnet
- Ortopedtekniska varbergs sjukhus
- Jobb tyresö kommun
- Emotionell instabil personlighet
- Transparent text indesign
2021-04-15
The company reversed from a loss 2021-04-14 Stock Quote Previous Close: Open: Volume: Exchange: Day High: Day Low: 52-Week High: 52-Week Low: Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. Sign up for email alerts.